Gene · 8291
Papers2,035
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,035
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Prevalence of a c.5979dupA Variant in the Dysferlin Gene (DYSF) in Individuals from a Semiarid Region of Brazil. | Curr Genomics | 2023 | 38235354 | PubTator, text mining | PubMed |
| Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data. | medRxiv | 2023 | 38196618 | PubTator, text mining | PubMed |
| Identifying Key Genes to the Early Diagnosis of Inflammatory Bowel Disease by Integrating Analysis at the Blood and Tissue Levels. | Gastroenterology Res | 2023 | 38186585 | PubTator, text mining | PubMed |
| Combining bioinformatics and machine learning algorithms to identify and analyze shared biomarkers and pathways in COVID-19 convalescence and diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 38169604 | PubTator, text mining | PubMed |
| Transcriptional Comparison of Human and Murine Retinal Neovascularization. | Invest Ophthalmol Vis Sci | 2023 | 38153746 | PubTator, text mining | PubMed |
| The Profiling of 179 miRNA Expression in Serum from Limb Girdle Muscular Dystrophy Patients and Healthy Controls. | Int J Mol Sci | 2023 | 38139231 | PubTator, text mining | PubMed |
| A Rare Variant in MDH2 (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree. | Cancers (Basel) | 2023 | 38136396 | PubTator, text mining | PubMed |
| Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach. | Front Neurol | 2023 | 38125829 | PubTator, text mining | PubMed |
| A precise prognostic signature in CTNNB1-mutant hepatocellular carcinoma: Prognosis prediction and precision treatment exploration. | Heliyon | 2023 | 38125518 | PubTator, text mining | PubMed |
| Five Padua days on muscle and mobility medicine (2024Pdm3) 27 February - 2 March, 2024 at Hotel Petrarca, Thermae of Euganean Hills, Padua, and San Luca Hall, Prato della Valle, Padua, Italy. | Eur J Transl Myol | 2023 | 38112609 | PubTator, text mining | PubMed |
| Novel five nucleotide deletion in dysferlin leads to autosomal recessive limb-girdle muscular dystrophy. | Physiol Rep | 2023 | 38110300 | PubTator, text mining | PubMed |
| Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | Cell Mol Life Sci | 2023 | 38092984 | PubTator, text mining | PubMed |
| Adaptive changes in the DNA damage response during skeletal muscle cell differentiation. | Front Cell Dev Biol | 2023 | 38089884 | PubTator, text mining | PubMed |
| Mutational spectrum and phenotypic variability of Duchenne muscular dystrophy and related disorders in a Bangladeshi population. | Sci Rep | 2023 | 38057384 | PubTator, text mining | PubMed |
| Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network. | Neurol Genet | 2023 | 38045992 | PubTator, text mining | PubMed |
| Methylmalonyl Coenzyme A (CoA) Epimerase Deficiency, an Ultra-Rare Cause of Isolated Methylmalonic Aciduria With Predominant Neurological Features. | Cureus | 2023 | 38034150 | PubTator, text mining | PubMed |
| Is MG53 a potential therapeutic target for cancer? | Front Endocrinol (Lausanne) | 2023 | 38033997 | PubTator, text mining | PubMed |
| AHNAKs roles in physiology and malignant tumors. | Front Oncol | 2023 | 38033502 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Genome Editing in LGMD2A/R1 Patient-Derived Induced Pluripotent Stem and Skeletal Muscle Progenitor Cells. | Stem Cells Int | 2023 | 38020204 | PubTator, text mining | PubMed |
| Mechanisms of Endothelial Cell Membrane Repair: Progress and Perspectives. | Cells | 2023 | 37998383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8291/papers?page=8